Brief report: Calculating the ankylosing spondylitis disease activity score if the conventional C-reactive protein level is below the limit of detection or if high-sensitivity C-reactive protein is used: An analysis in the DESIR cohort

Arthritis and Rheumatology

Volumn 67, Issue 2, 2015, Pages 408-413

  Machado, Pedro ^a,b   Navarro Compán, Victoria ^a,c   Landewé, Robert ^d,e   Van Gaalen, Floris A ^a   Roux, Christian ^f   Van Der Heijde, Désirée ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d Rheumatology and Clinical Immunology   (Netherlands)

^e Zuyderland Medical Centre   (Netherlands)

^f UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER;

ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE; ARTICLE; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MATHEMATICAL COMPUTING; PRIORITY JOURNAL; SPONDYLARTHRITIS; BIOLOGICAL MODEL; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; FRANCE; MATHEMATICS; METABOLISM; MULTICENTER STUDY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; COHORT STUDIES; FRANCE; HUMANS; LIMIT OF DETECTION; MATHEMATICS; MODELS, BIOLOGICAL; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

EID: 84922782453     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38921     Document Type: Article

References (17)

1. Lukas C, Landewe R, Sieper J, Dougados M, Davis J, Braun J, et al, for the Assessment of SpondyloArthritis international Society. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009; 68: 18-24.
2. Machado P, Landewe R, Lie E, Kvien TK, Braun J, Baker D, et al, for the Assessment of SpondyloArthritis international Society. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 2011; 70: 47-53.
3. Van der Heijde D, Lie E, Kvien TK, Sieper J, van den Bosch F, Listing J, et al, for the Assessment of SpondyloArthritis international Society (ASAS). ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 2009; 68: 1811-8.
4. Machado P, Landewe RB, Braun J, Baraliakos X, Hermann KG, Hsu B, et al. MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor. Ann Rheum Dis 2012; 71: 2002-5.
5. Pedersen SJ, Sorensen IJ, Garnero P, Johansen JS, Madsen OR, Tvede N, et al. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors. Ann Rheum Dis 2011; 70: 1375-81.
6. Machado PM, Landewe RB, van der Heijde DM,. Endorsement of definitions of disease activity states and improvement scores for the Ankylosing Spondylitis Disease Activity Score: results from OMERACT 10. J Rheumatol 2011; 38: 1502-6.
7. Arends S, Brouwer E, van der Veer E, Groen H, Leijsma MK, Houtman PM, et al. Baseline predictors of response and discontinuation of tumor necrosis factor-α blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study. Arthritis Res Ther 2011; 13: R94.
8. Fernandez-Espartero C, de Miguel E, Loza E, Tomero E, Gobbo M, Descalzo MA, et al, ESPERANZA Study Group. Validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme. Ann Rheum Dis 2014; 73: 1350-5
9. Popescu C, Trandafir M, Badica A, Morar F, Predeteanu D,. Ankylosing spondylitis functional and activity indices in clinical practice. J Med Life 2014; 7: 78-83.
10. Xu M, Lin Z, Deng X, Li L, Wei Y, Liao Z, et al. The Ankylosing Spondylitis Disease Activity Score is a highly discriminatory measure of disease activity and efficacy following tumour necrosis factor-α inhibitor therapies in ankylosing spondylitis and undifferentiated spondyloarthropathies in China. Rheumatology (Oxford) 2011; 50: 1466-72.
11. Dougados M, d'Agostino MA, Benessiano J, Berenbaum F, Breban M, Claudepierre P, et al. The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients. Joint Bone Spine 2011; 78: 598-603.
12. Rudwaleit M, Jurik AG, Hermann KG, Landewe R, van der Heijde D, Baraliakos X, et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis 2009; 68: 1520-7.
13. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A,. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21: 2286-91.
14. Fagerli KM, Lie E, van der Heijde D, Heiberg MS, Kaufmann C, Rodevand E, et al. Selecting patients with ankylosing spondylitis for TNF inhibitor therapy: comparison of ASDAS and BASDAI eligibility criteria. Rheumatology (Oxford) 2012; 51: 1479-83.
15. Vastesaeger N, Cruyssen BV, Mulero J, Gratacos Masmitja J, Zarco P, Almodovar R, et al, the REGISPONSER Working Group. ASDAS high disease activity versus BASDAI elevation in patients with ankylosing spondylitis as selection criterion for anti-TNF therapy. Reumatol Clin 2014; 10: 204-9.
16. Machado P, Landewe R,. Spondyloarthritis: is it time to replace BASDAI with ASDAS? Nat Rev Rheumatol 2013; 9: 388-90.
17. Poddubnyy DA, Rudwaleit M, Listing J, Braun J, Sieper J,. Comparison of a high sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis. Ann Rheum Dis 2010; 69: 1338-41.